» Articles » PMID: 30321791

Cognitive Control Neuroimaging Measures Differentiate Between Those with and Without Future Recurrence of Depression

Overview
Journal Neuroimage Clin
Publisher Elsevier
Specialties Neurology
Radiology
Date 2018 Oct 16
PMID 30321791
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Major Depressive Disorder (MDD) is a prevalent, disruptive illness. A majority of those with MDD are at high risk for recurrence and increased risk for morbidity and mortality. This study examined whether multimodal baseline (and retest) Cognitive Control performance and neuroimaging markers (task activation and neural connectivity between key brain nodes) could differentiate between those with and without future recurrence of a major depressive (MD) episode within one year. We hypothesized that performance and neuroimaging measures of Cognitive Control would identify markers that differ between these two groups.

Methods: A prospective cohort study of young adults (ages 18-23) with history (h) of early-onset MDD (N = 60), now remitted, and healthy young adults (N = 49). Baseline Cognitive Control measures of performance, task fMRI and resting state connectivity (and reliability retest 4-12 weeks later) were used to compare those with future recurrence of MDD (N = 21) relative to those without future recurrence of MDD (N = 34 with resilience). The measures tested were (1) Parametric Go/No-Go (PGNG) performance, and task activation for (2) PGNG Correct Rejections, (3) PGNG Commission errors, and (4 & 5), resting state connectivity analyses of Cognitive Control Network to and from subgenual anterior cingulate.

Results: Relative to other groups at baseline, the group with MDD Recurrence had less bilateral middle frontal gyrus activation during commission errors. MDD Recurrence exhibited greater connectivity of right middle frontal gyrus to subgenual anterior cingulate (SGAC). SGAC connectivity was also elevated in this group to numerous regions in the Cognitive Control Network. Moderate to strong ICCs were present from test to retest, and highest for rs-fMRI markers. There were modest, significant correlations between task, connectivity and behavioral markers that distinguished between groups.

Conclusion: Markers of Cognitive Control function could identify those with early course MD who are at risk for depression recurrence. Those at high risk for recurrence would benefit from maintenance or preventative treatments. Future studies could test and validate these markers as potential predictors, accounting for sample selection and bias in feature detection.

Citing Articles

Integrating dynamic psychophysiological indices across time and contexts: Elucidating mechanisms, risk markers, and intervention targets.

Stange J Psychophysiology. 2024; 61(10):e14630.

PMID: 39082831 PMC: 11473238. DOI: 10.1111/psyp.14630.


Functional connectivity of salience and affective networks among remitted depressed patients predicts episode recurrence.

Dunlop B, Cha J, Choi K, Nemeroff C, Craighead W, Mayberg H Neuropsychopharmacology. 2023; 48(13):1901-1909.

PMID: 37491672 PMC: 10584833. DOI: 10.1038/s41386-023-01653-w.


Trait- and state-like co-activation pattern dynamics in current and remitted major depressive disorder.

Liu C, Belleau E, Dong D, Sun X, Xiong G, Pizzagalli D J Affect Disord. 2023; 337:159-168.

PMID: 37245549 PMC: 10897955. DOI: 10.1016/j.jad.2023.05.074.


Reduced connectivity of the cognitive control neural network at rest in young adults who had their first drink of alcohol prior to age 18.

Jacobson M, Jenkins L, Feldman D, Crane N, Langenecker S Psychiatry Res Neuroimaging. 2023; 332:111642.

PMID: 37086604 PMC: 10247408. DOI: 10.1016/j.pscychresns.2023.111642.


Editorial: Highlights in psychopathology: Mental health among young adults.

Meneguzzo P, Passarotti A, Demir Kacan S Front Psychol. 2023; 14:1163957.

PMID: 37034910 PMC: 10074309. DOI: 10.3389/fpsyg.2023.1163957.


References
1.
Chekroud A, Lane C, Ross D . Computational Psychiatry: Embracing Uncertainty and Focusing on Individuals, Not Averages. Biol Psychiatry. 2017; 82(6):e45-e47. PMC: 5712404. DOI: 10.1016/j.biopsych.2017.07.011. View

2.
Collins G, Reitsma J, Altman D, Moons K . Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement. BMC Med. 2015; 13:1. PMC: 4284921. DOI: 10.1186/s12916-014-0241-z. View

3.
Kovacs M, Obrosky S, George C . The course of major depressive disorder from childhood to young adulthood: Recovery and recurrence in a longitudinal observational study. J Affect Disord. 2016; 203:374-381. PMC: 4975998. DOI: 10.1016/j.jad.2016.05.042. View

4.
Geller B, Craney J, Bolhofner K, Nickelsburg M, Williams M, Zimerman B . Two-year prospective follow-up of children with a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry. 2002; 159(6):927-33. DOI: 10.1176/appi.ajp.159.6.927. View

5.
Gueorguieva R, Chekroud A, Krystal J . Trajectories of relapse in randomised, placebo-controlled trials of treatment discontinuation in major depressive disorder: an individual patient-level data meta-analysis. Lancet Psychiatry. 2017; 4(3):230-237. PMC: 5340978. DOI: 10.1016/S2215-0366(17)30038-X. View